临床外科杂志 ›› 2020, Vol. 28 ›› Issue (7): 631-633.doi: 10.3969/j.issn.1005-6483.2020.07.010

• • 上一篇    下一篇

食管癌术后再发胸胃癌的外科治疗

  

  1. 430060 武汉大学人民医院胸外科(江万里、宋恒雅、杨森、黄杰、谢颂平);武汉大学人民医院光谷院区外科(曾文慧);河南省南阳市中心医院胸外科(王新) 江万里和曾文慧为共同第一作者
  • 出版日期:2020-07-20 发布日期:2020-07-20
  • 通讯作者: 谢颂平,Emial:songping0428@126.com

Surgical treatment of gastric cancer after esophagectomy

  1. Department of Thoracic Surgery,Renmin Hospital of Wuhan University,Wuhan 430060,China
  • Online:2020-07-20 Published:2020-07-20

摘要: 目的 探讨胃代食管术后再发胸胃癌外科治疗的可行性。
方法 回顾性分析武汉大学人民医院胸外科2013年6月~2018年12月期间收治或手术会诊的7例食管癌根治术并胃代食管术后再发胸胃癌病人行胸胃癌切除术的临床资料。
结果 本组7例病人中,男性6例,女性1例;年龄53~73岁,平均年龄63.2岁。首次手术与胸胃癌诊断间隔时间2.8~15年不等。本组无围术期死亡病例;手术时间170~580分钟,出血量350~1100ml;术后发生肺部感染2例,心律失常1例;颈部吻合口瘘1例,经切口换药两周后治愈。所有病例均获随访12个月,均获得正常进食,体重无下降。
结论 对于食管癌术后再发胸胃癌的病人,如果病变较为局限,外科切除是一个可供选择的治疗方案。

关键词: 胸胃癌, 食管癌术后, 食管切除术

Abstract: Objective To investigate the clinical efficacy of resection for Thoracic Gastric Cancer(TGC)after esophagectomy.
Methods Between June 2013 and December 2018,7 individuals with gastric cancer in the reconstructed gastric tube after esophagectomy in Renmin Hospital of Wuhan University were studied.
Results A total of 7 patients with TGCs were selected for this study.There were 6 male patients,the average age at diagnosis was 63.2 years(range:53~73)and that the interval between esophagectomy and cancer onset in the reconstructed gastric tube ranged from 2.8 to 15 years.There were no operative or in-hospital mortalities.The operative time ranged from 170min to 580min and the blood loss ranged from 350 to 1100ml.Postoperative pulmonary infection occurred in 2 cases and arrhythmia in 1 case.Neck anastomotic fistula occurred in 1 case,which was cured two weeks after dressing change through incision.The postoperative follow-up was made for 12 months in the whole patients and all of them were alive with eating normally.
Conclusion The development of TGC should be taken into consideration during the extended follow-up of patients undergoing esophagectomy for cancer.Gastrectomy should be considered the preferred treatment modality in operable patients with locally invasive tumor.

Key words: thoracic gastric cancer, postoperative of esophageal cancer, esophagectomy

[1] 张仁泉, 康宁, 宁郑浩. 《机器人辅助食管切除术中国临床专家建议(2019版)》解读[J]. 临床外科杂志, 2020, 28(1): 35-37.
[2] 吴开明, 姚龙, 康宁宁等. 进展期食管癌微创治疗术后远期疗效及预后因素分析[J]. 临床外科杂志, 2019, 27(7): 558-561.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 王延磊, 戴勇. 腹腔镜直肠癌全直肠系膜切除术质控要点[J]. 临床外科杂志, 2020, 28(5): 404 -406 .
[2] 邓祥兵, 张豪, 王自强. 盆内筋膜与盆内脏血管神经关系的研究进展及侧方淋巴结清扫术的技术改良[J]. 临床外科杂志, 2020, 28(5): 407 -411 .
[3] 韩方海, 钟广宇. 直肠癌全直肠系膜切除手术中保护盆腔自主神经的技术路径[J]. 临床外科杂志, 2020, 28(5): 412 -415 .
[4] 梁太平, 裴轶飞, 周建等. 主动脉夹层的治疗现状与未来[J]. 临床外科杂志, 2020, 28(6): 501 -503 .
[5] 李永康, 王南鹏, 杨能红. 左颈清术后合并双侧乳糜胸及肺炎一例[J]. 临床外科杂志, 2020, 28(6): 598 .
[6] 袁野 金润森 李鹤成. 机器人手术在肺癌外科的现状和展望[J]. 临床外科杂志, 2020, 28(7): 601 -604 .
[7] 李宗元 陈晓烨 刘伦旭. 机器学习在肺癌外科的研究进展[J]. 临床外科杂志, 2020, 28(7): 605 -607 .
[8] 滕啸 胡坚. 非小细胞肺癌新辅助免疫治疗前景[J]. 临床外科杂志, 2020, 28(7): 608 -610 .
[9] 张帆 谭锋维 薛奇 高树庚. 免疫检查点抑制剂在非小细胞肺癌新辅助治疗中的现状[J]. 临床外科杂志, 2020, 28(7): 611 -614 .
[10] 傅睿 钟文昭. 外科在Ⅲ期非小细胞肺癌多学科综合治疗中的地位[J]. 临床外科杂志, 2020, 28(7): 615 -617 .